Russia to mass-produce Covid-19 vaccine in India
RDIF has tied up with nearly a dozen contract manufacturers with idle capacity to produce some 1.5 billion doses of Sputnik V annually, more than what Serum and Bharat Biotech will jointly produce.
RDIF has tied up with nearly a dozen contract manufacturers with idle capacity to produce some 1.5 billion doses of Sputnik V annually, more than what Serum and Bharat Biotech will jointly produce.
The Pune-based company is pioneering the production of test kits to screen for Covid-19. With fresh funding, it hopes to rapidly ramp up capacity.